ArticleACS chemical biology2026
Repurposing Engineered Aminoacyl-tRNA Synthetases for Proximity-Dependent Protein Labeling through the Release of Aminoacyl-AMP Intermediate.
Article in ACS chemical biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Over the past two decades, engineering efforts have yielded aminoacyl-tRNA synthetases (aaRSs) capable of charging diverse noncanonical amino acids (ncAAs). Here, we report an unexpected and exploitable activity of these engineered aaRSs. In the absence of their cognate tRNA, aaRSs can release the ncAA-AMP intermediate, which labels proximal proteins via covalent acylation. Multiple different aaRSs exhibit this behavior, enabling both self-labeling and trans-labeling of proteins with ncAAs in vitro and in living cells. When using bioorthogonal ncAAs, the resulting labeled proteins can be further functionalized through bioorthogonal conjugation with a fluorophore for visualization or biotin for enrichment. Although labeling by existing aaRSs is slow, we provide preliminary evidence that improved activity is possible through further engineering. Taken together, these results establish a new potential approach for proximity-based protein labeling, analogous to BioID and TurboID. Many aaRSs are available to charge diverse ncAAs, creating opportunities for multiplexed labeling; i.e., different aaRS/ncAA pairs used simultaneously to probe multiple spatially/temporally distinct microenvironments.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.